Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-20 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −250 15,746
2024-02-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +1,144 $16.00 $18K 15,519
2024-02-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +1,714 $16.14 $28K 17,233
2024-02-16 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −2,858 $90.00 $257K 14,375
2024-02-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −1,144 0
2024-02-16 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −1,714 15,996
2024-02-15 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +776 $16.00 $12K 15,151
2024-02-15 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −776 $90.00 $70K 14,375
2024-02-15 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −776 1,144
2024-02-14 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +3,050 $16.00 $49K 17,425
2024-02-14 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −3,050 $90.03 $275K 14,375
2024-02-14 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,050 1,920
2024-02-07 Khayal Tamer I Chief Commercial Officer Exercise or conversion 10b5-1 +736 $16.00 $12K 15,111
2024-02-07 Khayal Tamer I Chief Commercial Officer Sale 10b5-1 −736 $90.09 $66K 14,375
2024-02-07 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −736 4,970
2024-02-06 Basile Edward M Director Sale 10b5-1 −5,773 $86.27 $498K 9,734
2024-02-06 Basile Edward M Director Sale 10b5-1 −1,384 $86.83 $120K 8,350
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion 10b5-1 +8,833 $13.28 $117K 21,908
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion 10b5-1 +3,644 $16.14 $59K 25,552
2024-02-01 Gordon Stephen Chief Financial Officer Exercise or conversion 10b5-1 +2,523 $38.46 $97K 28,075

Page 21 of 38 · 744 trades